Alpha Crest Capital Management LLC Neurocrine Biosciences Inc Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $78,317 - $91,746	851 Added 3.07%	28,555 $3.03 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $780,940 - $1.03 Million	10,304 Added 59.22%	27,704 $2.7 Million
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $1.05 Million - $1.37 Million	-14,463 Reduced 45.39%	17,400 $1.63 Million
Q4 2021 Feb 09, 2022	BUY	$79.65 - $106.22 $1.43 Million - $1.91 Million	18,016 Added 130.11%	31,863 $2.71 Million
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $942,895 - $1.08 Million	-10,941 Reduced 44.14%	13,847 $1.33 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $1.19 Million - $1.36 Million	13,252 Added 114.88%	24,788 $2.41 Million
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $38,793 - $52,894	443 Added 3.99%	11,536 $1.12 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $174,080 - $216,984	2,003 Added 22.04%	11,093 $1.06 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $692,832 - $973,755	7,205 Added 382.23%	9,090 $874,000
Q2 2020 Aug 12, 2020	SELL	$85.09 - $130.36 $920,078 - $1.41 Million	-10,813 Reduced 85.16%	1,885 $230,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $28,166 - $42,660	-375 Reduced 2.87%	12,698 $1.1 Million
Q4 2019 Feb 12, 2020	SELL	$86.8 - $118.57 $34,546 - $47,190	-398 Reduced 2.95%	13,073 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$83.82 - $101.5 $19,362 - $23,446	231 Added 1.74%	13,471 $1.21 Million
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $584,132 - $738,009	8,086 Added 156.89%	13,240 $1.12 Million
Q1 2019 May 10, 2019	BUY	$69.31 - $91.53 $357,223 - $471,745	5,154 New	5,154 $454,000

Others Institutions Holding NBIX

# of Institutions

631

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.08 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.47 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$756 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$378 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$274 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account